Latest Breaking News On - Biocryst pharmaceuticals of durham - Page 1 : comparemela.com

A drug produced by BioCryst Pharmaceuticals of Durham has won regulatory approval in Canada and Switzerland for preventing hereditary angioedema (HAE), a rare disease of swollen tissues caused by excessive fluid buildup.

United statesHenrik balle boysenJared rhinesBiocryst pharmaceuticals of durhamHealth canadaBiocryst pharmaceuticals